On the stock market since 2025, it operates in the world of consumer spending. It has 2,800 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
Executives buying with their own money is usually read as confidence in the company’s future.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
Clearly below the class average.
Clearly below the class average.
Clearly above the class average — a step short of the very top.
Clearly below the class average.
Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.
Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
An investor who bought at the very peak is down 67% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Over the last 3 years, sales grew about 23% a year on average.
Sales run at $200.3M a year. A small number, but proof the product has real buyers.
Over the last 12 months, company executives reported 45 buys and 32 sells. Management buying with its own money is usually read as a good sign.
A loss of $60K against $200.3M in annual sales.
Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 18/100. For a turnaround signal, the stock first needs to close the gap with the market.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 22/100.
On our five-subject report card, BRCB sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: BRCB is a high-risk stock — not yet profitable, and its future rides on its product catching on.
Analysts’ average target sits above today’s price, yet the valuation grade (23/100) says the stock isn’t cheap.